Citation 81782

MIMAKI,Y: KURODA,M: KAMEYAMA,A: YOKOSUKA,A: SASHIDA,Y:. (1998). STEROIDAL SAPONINS FROM THE RHIZOMES OF HOSTA SIEBOLDII AND THEIR CYTOSTATIC ACTIVITY ON HL-60 CELLS.. 48(8)

Citation Details

Title	STEROIDAL SAPONINS FROM THE RHIZOMES OF HOSTA SIEBOLDII AND THEIR CYTOSTATIC ACTIVITY ON HL-60 CELLS.
Authors	MIMAKI,Y: KURODA,M: KAMEYAMA,A: YOKOSUKA,A: SASHIDA,Y:
Year	1998
Volume	48
Issue	8

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Hosta sieboldii (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	GITOGENIN-3-O-BETA-D-GALACTOPYRANOSIDE	None
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GITOGENIN-3-O-BETA-D-GALACTOPYRANOSIDE	INACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GITOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GALACTOPYRANOSIDE]	None
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GITOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GITOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE]	None
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GITOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TIGOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE	None
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FUROSTAN-2-ALPHA-3-BETA-22-ZETA-26-TETROL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GALACTOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL-5-ALPHA: (25-R):	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTAN-2-ALPHA-3-BETA-22-ZETA-26-TETROL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-BETA-D-GALACTOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL-5-ALPHA: (25-R):	WEAK ACTIVITY
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FUROSTAN-2-ALPHA-3-BETA-22-ZETA-26-TETROL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-METHYL-5-ALPHA: (25-R):	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTAN-2-ALPHA-3-BETA-22-ZETA-26-TETROL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-METHYL-5-ALPHA: (25-R):	ACTIVE
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GITONIN,F:	None
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GITONIN,F:	ACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GITOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	None
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GITOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	WEAK ACTIVITY
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HECOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	None
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HECOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	WEAK ACTIVITY
20	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	MANOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	None
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	WEAK ACTIVITY
22	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	MANOGENIN,9-11-DEHYDRO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE	None
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOGENIN,9-11-DEHYDRO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE	WEAK ACTIVITY
24	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	MANOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	None
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
26	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MANOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	None
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
28	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MANOGENIN,9-11-DEHYDRO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	None
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOGENIN,9-11-DEHYDRO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
30	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MANOGENIN,9-11-DEHYDRO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	None
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MANOGENIN,9-11-DEHYDRO: 3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE]	WEAK ACTIVITY
32	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FUROSTAN-12-ONE,3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE],2-ALPHA-3-BETA-DIHYDROXY-26-BETA-D-GLUCOPYRANOSYL-OXY-22-METHOXY-5-ALPHA: (25-R):	None
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTAN-12-ONE,3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE],2-ALPHA-3-BETA-DIHYDROXY-26-BETA-D-GLUCOPYRANOSYL-OXY-22-METHOXY-5-ALPHA: (25-R):	INACTIVE
34	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FUROST-9-EN-12-ONE-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE,2-ALPHA-3-BETA-DIHYDROXY-26-BETA-D-GLUCOPYRANOSYL-OXY-22-METHOXY-5-ALPHA: (25-R):	None
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROST-9-EN-12-ONE-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE,2-ALPHA-3-BETA-DIHYDROXY-26-BETA-D-GLUCOPYRANOSYL-OXY-22-METHOXY-5-ALPHA: (25-R):	INACTIVE
36	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-2-ALPHA-3-BETA-12-BETA-TRIOL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE],5-ALPHA: (25-R):	None
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-2-ALPHA-3-BETA-12-BETA-TRIOL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE],5-ALPHA: (25-R):	INACTIVE

Citation 81782

Citation Details

Summary

Organisms and Their Experiments (1)

Hosta sieboldii (LILIACEAE)

Show SPARQL Queries (1)

Query 1